Search Results - "Uterine cervix tumor"

Refine Results
  1. 1
  2. 2

    Source: INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
    r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
    Instituto de Investigación Sanitaria La Fe (IIS La Fe)
    Boria, F, Chiva, L, Chacon, E, Zanagnolo, V, Fagotti, A, Kucukmetin, A, Mom, C, Chakalova, G, Shamistan, A, Malzoni, M, Narducci, F, Arencibia, O, Raspagliesi, F, Toptas, T, Cibula, D, Kaidarova, D, Meydanli, M M, Tavares, M, Golub, D, Perrone, A M, Poka, R, Zusterzeel, P L M, Aluloski, I, Goffin, F, Haidopoulos, D, Haller, H, Jach, R, Yezhova, I, Bernardino, M, Bharathan, R, Maenpaa, M M, Sukhin, V, Feron, J-G, Fruscio, R, Kukk, K, Ponce, J, Demirkiran, F, Vorgias, G, Povolotskaya, N, Coronado Martín, P J, Marina, T, Zapardiel, I, Bizzarri, N, Gorostidi, M, Gutierrez, M, Manzour, N & Berasaluce, A 2022, 'SUCCOR quality : validation of ESGO quality indicators for surgical treatment of cervical cancer', International Journal of Gynecological Cancer, vol. 32, no. 10, pp. 1236-1243. https://doi.org/10.1136/ijgc-2022-003790
    International Journal of Gynecological Cancer, 32, 10, pp. 1236-1243

  3. 3

    Source: Repositorio UCC
    Universidad Cooperativa de Colombia
    instacron:Universidad Cooperativa de Colombia

  4. 4

    Source: J Environ Public Health

    File Description: application/pdf

  5. 5
  6. 6

    Source: LANCET ONCOLOGY
    r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
    Institut d’Investigació Biomèdica Sant Pau (IIB Sant Pau)
    Universitat Politècnica de Catalunya (UPC)

  7. 7

    Source: Repositorio EdocUR-U. Rosario
    Universidad del Rosario
    instacron:Universidad del Rosario

    Subject Terms: Uterine Cervical Neoplasms, Procedures, Antibodies, Viral, Cancer prevention, Human papillomavirus type 18, Human papillomavirus type 6, Immunogenicity, Vaccine, 0302 clinical medicine, Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18, Human papillomavirus type 58, Virus antibody, Infection prevention, Human papillomavirus type 16, Uterine cervix carcinoma in situ, Antibody blood level, Viral, Human papillomavirus type 11, Treatment outcome, Drug safety, Human papillomavirus type 52, Priority journal, Immunoassay, Intramuscular, Antibody titer, Primary prevention, Incidence, Vaccination, Double blind procedure, Fetus wastage, 16. Peace & justice, Immunogenicity, Multicenter study, Normal human, 3. Good health, Clinical trial, Primary Prevention, Patient safety, Blood, Treatment Outcome, Human experiment, Randomized controlled trial, Seroconversion, Antibody response, Vaccine immunogenicity, Female, Patient Safety, Adenocarcinoma in situ, Drug, Human, Adult, Adolescent, Persistent virus infection, Immunology, Side effect, Uterine cervix cytology, Papillomavirus infection, Injections, Intramuscular, Article, Intention to treat analysis, Antibodies, Injections, Dose-Response Relationship, Young Adult, 03 medical and health sciences, Double-Blind Method, Virology, Virus DNA, Dose response, Humans, Human papillomavirus type 31, Human papillomavirus type 33, Human tissue, Anaphylaxis, Spontaneous abortion, Dose-Response Relationship, Drug, Papillomavirus Infections, Uterine cervix carcinoma, Patient compliance, Follow up, Appendicitis, Nonhuman, Human papillomavirus 6, Drug efficacy, Outcome assessment, Vulva cancer, Young adult, Statistics and numerical data, Vaginal intraepithelial neoplasia, Patient Compliance, Human papillomavirus type 45, Intramuscular drug administration, Uterine cervix tumor, Wart virus vaccine, Controlled study, Vaccine, Cancer incidence, Follow-Up Studies

    File Description: application/pdf

  8. 8
  9. 9

    Authors: Garland, SM Kjaer, SK Muñoz, N et al.

    Source: Clin Infect Dis
    Garland, S M, Kjaer, S K, Muñoz, N, Block, S L, Brown, D R, Dinubile, M J, Lindsay, B R, Kuter, B J, Perez, G, Dominiak-Felden, G, Saah, A J, Drury, R, Das, R & Velicer, C 2016, ' Impact and effectiveness of the quadrivalent human papillomavirus vaccine : A systematic review of 10 years of real-world experience ', Clinical Infectious Diseases, vol. 63, no. 4, pp. 519-527 . https://doi.org/10.1093/cid/ciw354
    Repositorio EdocUR-U. Rosario
    Universidad del Rosario
    instacron:Universidad del Rosario

    File Description: application/pdf

  10. 10

    Authors: Xue, Y Toh, S.Y He, P et al.

    Contributors: Xue, Y Toh, S.Y He, P et al.

    Source: Oncotarget. 6:34979-34991

  11. 11

    Source: IEEE Transactions on Image Processing. 24:1261-1272

    File Description: application/pdf

  12. 12
  13. 13
  14. 14
  15. 15

    Source: Journal of Enzyme Inhibition and Medicinal Chemistry. 24:844-849

    Subject Terms: squamous cell carcinoma, 0301 basic medicine, synthesis, Uterine Cervical Neoplasms, 01 natural sciences, 1,4 bis(5,6 dimethyl 1h benzo[d]imidazol 2 yl)butane, cytostasis, Bis-benzimidazoles, animal, uterine cervix tumor, antineoplastic agent, cancer cell, 1,3 bis(5,6 dimethyl 1h benzo[d]imidazol 2 yl)propane, 1,4 di(1h benzo[d]imidazol 2 yl)butane, breast tumor, article, breast adenocarcinoma, HeLa cell line, unclassified drug, 3. Good health, female, 1,2 bis(5,6 dimethyl 1h benzo[d]imidazol 2 yl) ethane, priority journal, DNA Topoisomerases, Type I, bis(5 methyl 1h benzo[d]imidazol 2 yl)methane, Mammalia, Carcinoma, Squamous Cell, bis-benzimidazole, cytotoxicity, Female, 1,2 di(1h benzo[d]imidazol 2 yl)ethane, spectroscopy, 1,3 bis(5 methyl 1h benzo[d]imidazol 2 yl)propane, in vitro study, 1,2 bis(5 methyl 1h benzo[d]imidazol 2 yl)ethane, biological activity, Antineoplastic Agents, Breast Neoplasms, chemistry, bis(5 methyl 1h benzo[d ]imidazol 2 yl)methane, 1,4 bis(5 methyl 1h benzo[d]imidazol 2 yl)butane, Structure-Activity Relationship, 03 medical and health sciences, plasmid, Cell Line, Tumor, di(1h benzo[d ]imidazol 2 yl)methane, methyl group, DNA topoisomerase I, Animals, Humans, controlled study, drug screening, human, malonic acid derivative, drug inhibition, DNA topoisomerase, structure activity relation, DNA topoisomerase inhibitor, adenocarcinoma, carbon, human cell, Spectrum Analysis, tumor cell line, benzimidazole derivative, di(1h benzo[d]imidazol 2 yl)methane, bis(5,6 dimethyl 1h benzo[d]imidazol 2 yl)methane, 0104 chemical sciences, Cytotostaticity, 1,3 di(1h benzo[d]imidazol 2 yl)propane, skin carcinoma, substitution reaction, drug synthesis, pathology, Benzimidazoles, Topoisomerase I Inhibitors, metabolism, HeLa Cells

  16. 16

    Source: Repositorio EdocUR-U. Rosario
    Universidad del Rosario
    instacron:Universidad del Rosario

    File Description: application/pdf

  17. 17

    Contributors: Mauri, D. Valachis, A. Polyzos, N. P. et al.

    Source: Clinical and Translational Oncology

    Subject Terms: Male, Uterine Cervical Neoplasms, Transrectal ultrasonography, Cervix, 0302 clinical medicine, Neoplasms, breast neoplasms, Skin cancer, Mass Screening, Breast, Health priorities, Male genital system examination, Middle aged, Melanoma, Sigmoidoscopy, Cancer, Skin, Prostatic Neoplasms/diagnosis, Prostate cancer, Greece, Statistics, Prostate, Colonoscopy, Middle Aged, Papanicolaou test, Multicenter study, 3. Good health, Clinical trial, Attitude to health, Digital rectal examination, Neoplasms/*prevention & control, Body mass, Health care planning, Screening, Prostate tumor, Female, Prostatic neoplasms, Thorax radiography, Uterine cervix cancer, Attitude to Health, Human, Mammography, Adult, Breast examination, Uterine cervical neoplasms, Echomammography, Colon, mammography, Breast tumor, Greece/epidemiology, Breast Neoplasms, Urinalysis, Article, Rectum, Prevention, Education, Cancer screening, Mammography/statistics & numerical data, Health Priorities, 03 medical and health sciences, Medical research, Physical examination, Uterine Cervical Neoplasms/diagnosis, Occult blood, Humans, Physical Examination, Aged, Blood cell count, Preventive medicine, Consultation, Physical Examination/statistics & numerical data, Breast Neoplasms/diagnosis, Prostatic Neoplasms, Mass screening, Mass Screening/*utilization, Colorectal cancer, Social status, Neoplasm, Patient participation, Breast neoplasms, Utilization review, Patient Participation, Uterine cervix tumor, Controlled study

  18. 18
  19. 19
  20. 20